MVision AI

Helsinki, Finland Founded: 2017 • Age: 9 yrs
An AI-enabled medical imaging platform for radiation therapy is developed.

About MVision AI

MVision AI is a Healthcare company based in Helsinki (Finland) founded in 2017 by Saad Ullah Akram, Mahmudul Hasan, and Heikki Arponen. An AI-enabled medical imaging platform for radiation therapy is developed. It operates on a AI-as-a-Service, Subscription Services, and HealthTech model. MVision AI has raised $6.56 million across 3 funding rounds from investors including Voima Ventures, J12 and Icebreaker.vc. Its chief executive, as recorded, is Mahmudul Hasan. MVision AI offers products and services including GBSâ„¢, Contour+, Guide, Verify, and Dose+. Its focus areas include Health Technology and Medical Software. Its legal entity is MVision AI Inc.

Company details

AI-driven software solutions for radiotherapy planning and treatment optimization are provided by MVision AI. Focus is placed on guideline-based segmentation and dose prediction through products like GBS, Contour, Guide, Verify, and Dose. The healthcare sector, specifically radiation oncology, is served by integrating these tools with existing treatment planning systems. Efficiency in clinical workflows is enhanced, reducing contouring time significantly. Worldwide, leading clinics rely on these solutions to treat cancer patients, aiming for same-day treatment delivery. Innovation is driven by collaboration with radiation oncologists, therapists, and medical physicists to improve patient outcomes.

  • Headquarters Helsinki, Finland
  • Founders Saad Ullah Akram, Mahmudul Hasan, Heikki Arponen
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website mvision.ai
  • Social LinkedIn X Facebook YouTube
  • Legal Name Mvision Ai Inc.
Key Metrics
  • Total Equity Funding
    $6.56M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.25M (USD), Debt – Conventional

    Jun 2025

  • Investors

Products & Services of MVision AI

MVision AI offers a comprehensive portfolio of products and services, including GBS™, Contour+, Guide, Verify, and Dose+.

GBS™
Radiotherapy Software

Guideline-based segmentation suite for precise radiotherapy planning.

Contour+
Radiotherapy Software

AI-powered auto-contouring for fast, consistent radiotherapy planning.

Guide
Radiotherapy Software

Training environment for guideline expertise in contouring practice.

Verify
Radiotherapy Software

Contour comparison tool for analyzing accuracy across sources.

Dose+
Radiotherapy Software

AI-guided dose prediction for optimized radiotherapy treatment plans.

Apps and channels of MVision AI

its YouTube channel MVision AI has 46 subscribers and 8 videos.

MVision AI
YouTube 46 subscribers 8 videos Science & Technology
Open channel

Videos from MVision AI

The most watched videos on MVision AI's YouTube channel, MVision AI (46 subscribers). Click a video to play it here.

ESTRO 2020 E-unveiling
561 views
CONTOUR+ | NEW LAUNCH | V 1.2.4
335 views
MVision
274 views
Webinar - Clinical User Experience with MVision AI
260 views

More on MVision AI.

Funding Insights of MVision AI

MVision AI has successfully raised a total of $6.56M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.25 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.56M
  • Total Rounds 3
  • Last Round Debt – Conventional — $3.25M
  • First Round $730,799

    (May 2018)

  • Investors Count 7

All 3 funding rounds of MVision AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2025$3.25MDebt – Conventional––
Mar 2023$5.83MSeries A–Voima Ventures
May 2018$730,799Seed––
Valuation history

7 investors in total: 5 institutional and 2 angel.

Investors in MVision AI

MVision AI has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Voima Ventures, J12 and Icebreaker.vc.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Funding is provided for deep tech ventures in Nordics.
voimaventures.comHelsinki, Finland
Seed and early-stage tech investments are targeted in Finland.
icebreaker.vcHelsinki, Finland
nuard.com
j12.vc
businessfinland.fi

Otto Söderlund

unknown_0a16da4025e0464ab

Asko Schrey

unknown_15c7e5cd37d642f7b
Premium access

Investor details for MVision AI

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MVision AI

15 people are tracked at MVision AI (8 in leadership, 7 in team).

NameRoleGroup
Saad Ullah Akram
Co-FounderLeadership
Mahmudul Hasan
Co-Founder & CEOLeadership
Heikki Arponen
Co-FounderLeadership
Dr. Britta Schürmann
Head of Sales Business Development EMEALeadership
Joona Hartman
VP of EngineeringLeadership
Kalpana Jha
VP Of Regulatory And Market Strategy - Leadership TeamLeadership
Jarkko Niemelä
Chief Product OfficerLeadership
Alex Plowman
Chief Revenue OfficerLeadership
Brandi Harrell Hackler
Business Development Representative at MVision AITeam
Jani Pehkonen
Product OwnerTeam
Saim Akhtar
Software DeveloperTeam
Bhavana Bhisetty
Regulatory Affairs SpecialistTeam
Szabolcs-Botond Lőrincz-Molnár
Machine Learning Team LeadTeam
Anton Naumov
Machine Learning ResearcherTeam
Pauliina Paavilainen
Machine Learning ResearcherTeam
Premium access

Complete people profiles for MVision AI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of MVision AI

3 dated milestones of MVision AI across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded MVision AI is founded.
  2. Funding First funding round of $731K.
  3. Funding Latest funding round, Debt – Conventional, of $3.2M.

Web traffic of MVision AI

The website of MVision AI (mvision.ai) receives about 9.5K visits a month.

  • Monthly visits
    9.5K

    ▼ 14.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mvision Ai

Premium access

Complete news archive for MVision AI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MVision AI

MVision AI was founded in 2017 and raised its 1st funding round 1 year after it was founded.

MVision AI is headquartered in Helsinki, Finland.

Mahmudul Hasan is the CEO of MVision AI, as recorded in our data. They have also founded this company.

MVision AI is a funded company, having raised a total of $6.56M across 3 funding rounds to date. The company's 1st funding round was a Seed of $730.8K, raised on May 2018.

AI-driven software solutions for radiotherapy planning and treatment optimization are provided by MVision AI. Focus is placed on guideline-based segmentation and dose prediction through products like GBS, Contour, Guide, Verify, and Dose. The healthcare sector, specifically radiation oncology, is served by integrating these tools with existing treatment planning systems. Efficiency in clinical workflows is enhanced, reducing contouring time significantly. Worldwide, leading clinics rely on these solutions to treat cancer patients, aiming for same-day treatment delivery. Innovation is driven by collaboration with radiation oncologists, therapists, and medical physicists to improve patient outcomes.

MVision AI offers GBSâ„¢, Contour+, Guide, Verify, and Dose+.

MVision AI has 7 investors. Key investors include Voima Ventures, J12, Icebreaker.vc, Otto Söderlund, and Asko Schrey.

MVision AI operates through Mvision Ai Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available